title: Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis.
authors.forename: Amandine
authors.initials: A
authors.lastname: Benoit
authors.forename: François
authors.initials: F
authors.lastname: Ducray
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Cartalat-Carel
authors.forename: Dimitri
authors.initials: D
authors.lastname: Psimaras
authors.forename: Damien
authors.initials: D
authors.lastname: Ricard
authors.forename: Jérôme
authors.initials: J
authors.lastname: Honnorat
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068258:Bevacizumab; D001933:Brain Stem / Q000187:drug effects / Q000473:pathology* / Q000528:radiation effects; D002277:Carcinoma; D002945:Cisplatin / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D000077274:Nasopharyngeal Carcinoma; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D009336:Necrosis / Q000188:drug therapy / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D011832:Radiation Injuries / Q000188:drug therapy* / Q000473:pathology; D011878:Radiotherapy / Q000009:adverse effects; D013702:Temporal Lobe / Q000187:drug effects / Q000473:pathology* / Q000528:radiation effects
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D000068258:Bevacizumab; D011239:Prednisolone; D002945:Cisplatin; D005472:Fluorouracil